Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
43.20%
↑ 455% above average
Average (39q)
7.79%
Historical baseline
Range
High:107.18%
Low:-54.56%
CAGR
+0.6%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 43.20% |
| Q2 2025 | 107.18% |
| Q1 2025 | -54.56% |
| Q4 2024 | -1.14% |
| Q3 2024 | -2.97% |
| Q2 2024 | 26.07% |
| Q1 2024 | -36.30% |
| Q4 2023 | 3.35% |
| Q3 2023 | 5.92% |
| Q2 2023 | 3.19% |
| Q1 2023 | -2.93% |
| Q4 2022 | -1.32% |
| Q3 2022 | 11.73% |
| Q2 2022 | -0.31% |
| Q1 2022 | -16.73% |
| Q4 2021 | 12.90% |
| Q3 2021 | -0.27% |
| Q2 2021 | 17.09% |
| Q1 2021 | -23.86% |
| Q4 2020 | 12.77% |
| Q3 2020 | 15.69% |
| Q2 2020 | 11.87% |
| Q1 2020 | -36.70% |
| Q4 2019 | -3.71% |
| Q3 2019 | 28.32% |
| Q2 2019 | 48.72% |
| Q1 2019 | -47.41% |
| Q4 2018 | 98.96% |
| Q3 2018 | -19.01% |
| Q2 2018 | 17.28% |
| Q1 2018 | -26.59% |
| Q4 2017 | 8.50% |
| Q3 2017 | 33.42% |
| Q2 2017 | 24.75% |
| Q1 2017 | -40.35% |
| Q4 2016 | 32.30% |
| Q3 2016 | 21.63% |
| Q2 2016 | -17.70% |
| Q1 2016 | 23.89% |
| Q4 2015 | 34.71% |